Cancer BiologyMolecular CellPeer-reviewed
The FANCM-RMI1/2 complex promotes genomic instability and PARP inhibitor sensitivity in BRCA2-deficicient cells.
François Dossin, Mikaël Attia, Fabricio Montero Zuniga…·Ludovic Deriano
This study identifies FANCM-RMI1/2 as a driver of PARP inhibitor sensitivity in BRCA2-deficient cells, revealing distinct adaptation mechanisms between BRCA1 and BRCA2 loss.
DOI 10.1016/j.molcel.2026.09.017